Société de Therapeutique Marocaine S.A. (CBSE:SOT)
Morocco flag Morocco · Delayed Price · Currency is MAD
1,787.00
+37.00 (2.11%)
At close: Dec 4, 2025

Société de Therapeutique Marocaine Company Description

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco.

It offers products in various therapeutic areas, such as allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics.

The company also provides its products in various forms, including tablets, capsules, pouches, syrups, suspensions, powders, collyriums, flexible pouches, suppositories, creams and pomades, injectable solutions, and self-injectable syringes.

In addition, it imports licensed medicines and dental products, as well as biotechnology products; and involved in subcontracted production.

The company exports its products to Europe, Maghreb, Sub-Saharan Africa, and the Persian Gulf. Société de Therapeutique Marocaine S.A. was founded in 1976 and is based in Bouskoura, Morocco.

Société de Therapeutique Marocaine S.A.
Country Morocco
Founded 1976
Industry Pharmaceutical Preparations
Employees 1,316
CEO Lamia Tazi

Contact Details

Address:
Zone industrielle de Bouskoura
Bouskoura, 27182
Morocco
Phone 212 5 22 43 70 40
Website sothema.com

Stock Details

Ticker Symbol SOT
Exchange Casablanca Stock Exchange
Fiscal Year January - December
Reporting Currency MAD
SIC Code 2834

Key Executives

Name Position
Lamia Tazi Chief Executive Officer
Adnane Hilal Chief Financial Officer
Mehdi Zaghloul Chief Operating Officer